Medplus Health Services · NSE: MEDPLUS · BSE: 543427
Q4 FY22 results · Jan–Mar 2022
Medplus Health Services reported revenue from operations of ₹965.91 crore and net profit of ₹11.43 crore for Q4 FY22 (Jan–Mar 2022), on a consolidated basis.
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 965.91 | — | — | 933.45 | +3.5% |
| Other income | 13.05 | — | — | 7.33 | +77.9% |
| Total income | 978.96 | — | — | 940.79 | +4.1% |
| Profit before tax | 12.63 | — | — | 21.75 | −41.9% |
| Net profit for the period | 11.43 | — | — | 16.92 | −32.4% |
| Attributable to shareholders of the company | 11.73 | — | — | 17.17 | −31.7% |
| EPS, basic (₹) | 0.99 | — | — | 1.53 | −35.3% |
| Net margin (%) | 1.2 | — | 1.8 |
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 38.82 | — | — | 24.71 | +57.1% |
| Other income | 6.21 | — | — | 1.12 | +453.6% |
| Total income | 45.03 | — | — | 25.83 | +74.3% |
| Profit before tax | 0.92 | — | — | (1.21) | Turned profit |
| Net profit for the period | 0.92 | — | — | (1.21) | Turned profit |
| EPS, basic (₹) | 0.08 | — | — | (0.11) | Turned profit |
| Net margin (%) | 2.4 | — | -4.9 |
Consolidated
- Filed with BSE
- 13 Jun 2022, 16:13 IST
- Board meeting
- 30 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 Jun 2022, 16:13 IST
- Board meeting
- 30 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE